Clicky

Champions Oncology, Inc.(CSBR)

Description: Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assists physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. It also offers POS products, including personalized tumor boards that are designed to provide access to oncologists with expertise in particular tumor types; and gene sequencing that analyzes the genetic makeup of patient's tumor for the purpose of identifying useful drugs. In addition, the company offers Translational Oncology Solutions (TOS), including a preclinical Tumorgraft platform to pharmaceutical and biotechnology companies that uses vivo studies, which rely on implanting multiple tumors from TumorBank in mice and testing the therapy of interest on tumors. Further, it provides a bank of tumors that are acquired, collected, processed, validated, and stored for the use in TOS. The company markets its products through Internet, word of mouth, and a network of sales force. It serves patients, physicians, and drug development companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011 to reflect its new focus on developing technologies to personalize the development and use of oncology drugs. Champions Oncology, Inc. is headquartered in Hackensack, New Jersey.


Keywords: Bank Biotechnology Cancer Technology Solutions Tumor Drug Development Cancer Care Basilea Pharmaceutica Molecular Partners Oncology Services Patient's Tumor

Home Page: www.championsoncology.com

CSBR Technical Analysis

One University Plaza
Hackensack, NJ 07601
United States
Phone: 201 808 8400


Officers

Name Title
Dr. Ronnie Morris M.D. Pres, CEO & Director
Mr. David Barry Miller M.B.A. Chief Financial Officer
Dr. Maria Mancini Ph.D. Chief of Scientific Operations
Mr. David DeOrnellis BS, CMAR, CPIA, RLATG Exec. VP of Global Laboratory Operations
Dr. Michael Ritchie M.B.A., Ph.D. Chief Commercial Officer
Dr. Karin Abarca Heidemann Ph.D. Exec. VP of Global Scientific Operations

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 43.4783
Trailing PE: 436
Price-to-Book MRQ: 9.8273
Price-to-Sales TTM: 1.3785
IPO Date: 2003-01-10
Fiscal Year End: April
Full Time Employees: 230
Back to stocks